Evidence map›Paper›PMID 33672757›Full record

ArticleNanomaterials (Basel, Switzerland)2021

Towards the Development of Antioxidant Cerium Oxide Nanoparticles for Biomedical Applications: Controlling the Properties by Tuning Synthesis Conditions.

Noemi Gallucci, Giuseppe Vitiello, Rocco Di Girolamo, Paola Imbimbo, Daria Maria Monti, Oreste Tarallo, Alessandro Vergara, Irene Russo Krauss, Luigi Paduano

Open access · goldAbstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. An Alternative Exploitation ofMolecules (Basel, Switzerland) · 2023
    Article
  7. Controlling the Adsorption of β-Glucosidase onto Wrinkled SiOLangmuir : the ACS journal of surfaces and colloids · 2023
    Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Noemi GallucciDepartment of Chemical Sciences, University of Naples Federico II, 80126 Naples, Italy.
Giuseppe VitielloCSGI, Center for Colloid and Surface Science, 50019 Sesto Fiorentino, Italy.ORCID 0000-0003-3389-6942
Rocco Di GirolamoDepartment of Chemical Sciences, University of Naples Federico II, 80126 Naples, Italy.ORCID 0000-0001-8815-2997
Paola ImbimboDepartment of Chemical Sciences, University of Naples Federico II, 80126 Naples, Italy.
Daria Maria MontiDepartment of Chemical Sciences, University of Naples Federico II, 80126 Naples, Italy.
Oreste TaralloDepartment of Chemical Sciences, University of Naples Federico II, 80126 Naples, Italy.ORCID 0000-0001-5952-523X
Alessandro VergaraDepartment of Chemical Sciences, University of Naples Federico II, 80126 Naples, Italy.
Irene Russo KraussDepartment of Chemical Sciences, University of Naples Federico II, 80126 Naples, Italy.ORCID 0000-0001-8124-6034
Luigi PaduanoDepartment of Chemical Sciences, University of Naples Federico II, 80126 Naples, Italy.ORCID 0000-0002-1105-4237
University of Naples Federico II · ITConsorzio Interuniversitario per lo Sviluppo dei Sistemi a Grande Interfase · IT

Funding

Regional Operational Programme (P.O.R.) Campania "De-544 velopment of novel therapeutic approaches for treatment-resistant neoplastic diseases"
6 · The paper itself

Abstract

In this work CeO

Indexed as

cerium oxidefunctionalized nanoparticlesredox activityROS inhibiting activitysynthesis conditionwet-chemistry

Identifiers

PMID33672757
PMCPMC7924622
OpenAlexW3131014805

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.